BackLisata Therapeutics Overview

Lisata Therapeutics Current Cash

Track Lisata Therapeutics's current cash ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$10.44M
↓ 37.97% YoYΔ $-6.39M vs prior year quarter

Peer trimmed avg / median

Loading

Lisata Therapeutics Current Cash History

Loading

Lisata Therapeutics vs. peers: Current Cash Comparison

Loading

Lisata Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lisata Therapeutics (LSTA) FAQ

As of the most recent data (June 2026), LSTA shows a current cash of $10M. That compares with $17M in the prior-year period — down 38.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSTA's current cash is now $10M (was $17M) — a 38.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lisata Therapeutics is outperforming or lagging.

Tracking LSTA's current cash over time shows whether Lisata Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $17M in the prior-year period — down 38.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Lisata Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $10M) with ownership activity and broader fundamentals.

Lisata Therapeutics's current cash is $10M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.